Decreased salivary lactoferrin levels are specific to Alzheimer's disease
Openalex
Resumen
Instituto de Salud Carlos III (FIS15/00780, FIS18/00118), FEDER, Comunidad de Madrid (S2017/BMD-3700; NEUROMETAB-CM), and CIBERNED (PI2016/01) to E.C.; Spanish Ministry of Economy and Competitiveness (SAF2017-85310-R) to J.L.C., and (PSI2017-85311-P) to M.A.; International Centre on ageing CENIE-POCTEP (0348_CIE_6_E) to M.A.; Instituto de Salud Carlos III (PIE16/00021, PI17/01799), to H.B.
Cómo citar
Marta González‐Sánchez, & Fernando Benito Bartolomé, & Desireé Antequera, & Verónica Puertas‐Martín, & Pilar González, & Adolfo Gómez‐Grande, & Sara Llamas‐Velasco, & Alejandro Herrero-San Martín, & David A. Pérez-Martínez, & Alberto Villarejo‐Galende, & Mercedes Atienza, & Miriam Palomar-Bonet, & José L. Cantero, & George Perry, & Gorka Orive, & Borja Ibáñez, & Héctor Bueno, & Valentı́n Fuster, & Eva Carro (2020). Decreased salivary lactoferrin levels are specific to Alzheimer's disease. https://doi.org/10.1016/j.ebiom.2020.102834